Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with atopic asthma \>1 year duration diagnosed according to the GINA guidelines.
Subjects must weigh at least 50 kg to participate in the study, and must have a body mass index (BMI) within the range of 18 - 39 kg/m2.
Asthma which is not adequately controlled on current treatment, as demonstrated by an Asthma Control Questionnaire (ACQ) score of \> 1.5.
FEV1 40 to 90% of predicted.
You may not be if
Diagnosed with COPD as defined by the GOLD guidelines
Subjects who have had a respiratory tract infection within 4 weeks prior to screening.
Women of child-bearing potential must use highly effective methods of contraception during dosing and for at least 18 weeks after last study drug administration
